Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Department of Pathology and Laboratory Medicine, |
RCV000500112 | SCV000592728 | uncertain significance | not provided | no assertion criteria provided | clinical testing | The PKD1 c.215+4_215+5insACAG variant was not identified in the literature nor was it identified in the 1000 Genomes Project , NHLBI GO Exome Sequencing Project or the Exome Aggregation Consortium (March 14, 2016) databases. In addition, the variant was not identified in the Clinvitae, ClinVar, GeneInsight COGR, MutDB, ADPKD Mutation Database, PKD1-LOVD and PKD1-LOVD 3.0 databases. This c.215+4_215+5insACAG variant is located in the 5' splice region but does not affect the invariant +1 and +2 positions. However, positions +3 to +6 are part of the splicing consensus sequence and variants involving these positions sometimes affect splicing. Five of 5 in-silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) predict the creation of a new 5’ splice donor site, increasing the likelihood this variant may have clinical significance. In summary, based on the above information, the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. |